CUPERTINO, Calif., Jan. 7, 2021 /PRNewswire-PRWeb/ -- Protein Metrics Inc., a premier provider of mass spectrometry software for protein characterization, announced today a seventh consecutive year of record revenue growth along with annualized bookings from biopharmaceutical customers growing at over 30% over the previous year. With continued expansion of market awareness, the Byos® platform has solidified its position as the benchtop analytical workhorse for protein characterization in biopharmaceutical laboratories. Early uptake of the Enterprise Byosphere™ platform has been robust and the company expects this platform to drive expanded growth by connecting customers' critical data and results to their internal stakeholders.
"Even though our customers have faced a year of unparalleled uncertainty, we are delighted that they have continued to not only maintain, but expand their commitment with us," said Eric Carlson, Ph. D., President and CEO. "This significant increase in revenue is a testament to the trust shown in the accuracy and reliability of our software as well as the confidence placed in our expanding global team."
In 2020, Protein Metrics saw several notable highlights:
- The leadership team was strengthened with the addition of Kevin Cronin as Vice President of Corporate Development. His presence will serve to strengthen relationships with partners as we drive adoption with mutual customers and to help the Company identify and explore new growth areas of expansion and investment.
- Protein Metrics and Intabio inked their agreement to provide a custom solution for Intabio Blaze™ users worldwide.(https://www.prnewswire.com/news-releases/intabio-and-protein-metrics-launch-strategic-partnership-301021330.html)
- Protein Metrics had three new patents issued last year. This significant corpus of IP assets underscores the company's commitment to reinvest for future growth.
- Release and early adoption of the Byosphere™ enterprise platform on cloud and on-premise solutions.
"As the industry continues to focus on complex biological molecules, the ability to characterize the burgeoning volume of biotherapeutics and share results becomes increasingly critical" added Dr Carlson. "Byosphere is delivering measurable impact for our clients across departments from cell line selection, to process development, to regulatory filings. Protein Metrics is well positioned to deliver value to academic institutions, pharmaceutical companies, and small biotechnology organizations alike."
About Protein Metrics
Protein analysis should never be limited by software. With a clear focus on protein characterization, Protein Metrics' vendor-neutral software allows scientists to use data generated on analytical instruments like mass spectrometers to quickly identify and report protein sequences as well as any variations from the expected form. We innovate so that biopharmaceutical companies and university research labs can achieve confident results from their analysis and reporting. With our customers, we are boldly advancing protein characterization. Protein Metrics is headquartered in Cupertino, CA at the crossroads of computing and biotechnology in the San Francisco Bay Area. For more information, visit http://www.proteinmetrics.com.
Sanjay Sanghani, Protein Metrics, Inc, +1 7742178463, [email protected]
SOURCE Protein Metrics, Inc